马斯克脑机公司对手，强脑科技拟IPO前融资估值超13亿美元

Group 1 - The core viewpoint of the article highlights that Zhejiang Qiangnao Technology is negotiating financing with a valuation exceeding $1.3 billion, potentially leading to an IPO in Hong Kong or mainland China [1] - Qiangnao Technology, founded by Harvard alumnus Han Bicheng in 2015, competes with Elon Musk's Neuralink and is part of the "Six Little Dragons" in Hangzhou, focusing on developing bionic limbs and brain-computer interface technologies [1] - The company is reportedly in talks for approximately $100 million in pre-IPO financing and has begun preparing the necessary documents for listing, although specific details regarding the listing location remain undecided [1] Group 2 - The financing activities of Qiangnao Technology reflect a growing interest among investors in a new generation of startups aiming to disrupt the technology sector and advance innovations in AI and robotics [1] - Qiangnao Technology is not the only Chinese startup challenging Neuralink; for instance, Shanghai Jieti Medical completed a Series B financing of 350 million RMB (approximately $48.7 million) earlier this year and initiated China's first clinical trial for an invasive brain-computer interface [1] - Han Bicheng indicated in an interview that the company is considering expanding its business into Hong Kong [1]